FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773881003: Antiparkinson therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726863016 Antiparkinson therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726864010 Antiparkinson therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiparkinson therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Generic Stalevo 125mg/31.25mg/200mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patches Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Procyclidine 2.5mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 6mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Trihexyphenidyl 500micrograms/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 8mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Procyclidine 5mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours transdermal patches Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 6.25mg/25mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Procyclidine 5mg/5ml oral solution sugar free Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine 200micrograms/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 1mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Trihexyphenidyl 10mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Entacapone 200mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 12mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Benzatropine 2mg/2ml solution for injection ampoules Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine 1mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 4mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 10mg/40mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine 20mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Entacapone 400mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine 5mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Levodopa 25mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Amantadine 50mg/5ml oral solution sugar free Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Pramipexole 1.57mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Procyclidine 5mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine 2.5mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Ropinirole 1mg oral powder sachets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Entacapone 400mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Generic Neupro transdermal patches starter pack Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Safinamide 50mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Orphenadrine 25mg/5ml oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Piribedil 50mg modified-release tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Opicapone 50mg capsules Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Orphenadrine 50mg/5ml oral solution sugar free Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Piribedil 20mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Safinamide 100mg tablets Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 4 of 4

This concept is not in any reference sets

Back to Start